CBD helped manage chronic pain and mood disorder in a patient with neurofibromatosis
A case report describes CBD use for managing chronic pain and mood disorder in a patient with neurofibromatosis type 1, a genetic condition causing painful tumors and significant psychological distress.
Quick Facts
What This Study Found
CBD was used to manage chronic pain from neurofibromas and associated mood disorder (depression and anxiety) in a patient with neurofibromatosis type 1, leveraging its reported anti-inflammatory, analgesic, mood-stabilizing, and anxiolytic properties.
Key Numbers
NF1 is a common genetic disorder. Pain sources include plexiform and subcutaneous neurofibromas, musculoskeletal symptoms, and headaches. CBD used for both pain and mood symptoms.
How They Did This
Single patient case report describing CBD use for NF1-related pain and mood disorder, with narrative review of CBD's pharmacological properties.
Why This Research Matters
Neurofibromatosis causes chronic pain that is difficult to treat with conventional medications, and the psychological burden is significant. This case adds to the growing interest in CBD for complex pain conditions with comorbid mood disorders.
The Bigger Picture
Complex chronic conditions that combine pain with psychological distress are often poorly served by single-target medications. CBD's reported multi-target effects (anti-inflammatory, analgesic, anxiolytic) make it an intriguing option for such conditions, though evidence remains anecdotal.
What This Study Doesn't Tell Us
Single case report, the weakest level of clinical evidence. No control comparison. Subjective outcome assessment. Cannot generalize to other NF1 patients. No standardized dosing protocol described.
Questions This Raises
- ?Would CBD show benefit in a controlled trial of NF1 pain?
- ?Which of CBD's mechanisms is most relevant for neurofibroma pain?
- ?Could CBD reduce opioid use in NF1 patients with chronic pain?
Trust & Context
- Key Stat:
- CBD used for both chronic pain and mood disorder in a genetic tumor condition
- Evidence Grade:
- Preliminary: single case report without controls or standardized outcomes.
- Study Age:
- Published in 2019.
- Original Title:
- Cannabidiol (CBD) for Treatment of Neurofibromatosis-related Pain and Concomitant Mood Disorder: A Case Report.
- Published In:
- Cureus, 11(12), e6312 (2019)
- Authors:
- Hegazy, Omar, Platnick, Howard(2)
- Database ID:
- RTHC-02069
Evidence Hierarchy
Describes what happened to one person or a small group.
What do these levels mean? →Frequently Asked Questions
Can CBD help with nerve tumor pain?
This case report describes one patient with neurofibromatosis who used CBD for pain and mood symptoms. While suggestive, a single case cannot prove effectiveness. Controlled trials would be needed to recommend CBD for this condition.
Why use CBD for a condition with both pain and mood issues?
CBD has reported anti-inflammatory, analgesic, and anxiolytic properties. For conditions where pain and psychological distress co-occur, a single agent affecting multiple symptoms is attractive, though evidence for each application is still developing.
Read More on RethinkTHC
- CBD-oil-quality-guide
- anxiety-medication-after-quitting-weed
- cannabis-chemotherapy-nausea
- cannabis-chronic-pain-research
- cannabis-epilepsy-CBD-Epidiolex
- cbd-anxiety-research-evidence
- cbd-for-weed-withdrawal
- cbd-vs-thc-difference
- medical-benefits-of-cannabis
- quitting-weed-before-surgery
- quitting-weed-medication-interactions
- quitting-weed-pregnancy
- quitting-weed-pregnant
- seniors-older-adults-cannabis-risks-medications
- weed-breastfeeding-THC-breast-milk
Cite This Study
https://rethinkthc.com/research/RTHC-02069APA
Hegazy, Omar; Platnick, Howard. (2019). Cannabidiol (CBD) for Treatment of Neurofibromatosis-related Pain and Concomitant Mood Disorder: A Case Report.. Cureus, 11(12), e6312. https://doi.org/10.7759/cureus.6312
MLA
Hegazy, Omar, et al. "Cannabidiol (CBD) for Treatment of Neurofibromatosis-related Pain and Concomitant Mood Disorder: A Case Report.." Cureus, 2019. https://doi.org/10.7759/cureus.6312
RethinkTHC
RethinkTHC Research Database. "Cannabidiol (CBD) for Treatment of Neurofibromatosis-related..." RTHC-02069. Retrieved from https://rethinkthc.com/research/hegazy-2019-cannabidiol-cbd-for-treatment
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkTHC research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.